3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Thyroid Carcinoma, Anaplastic
4
Thyroid Neoplasms
3
Neuroendocrine Tumors
3
Neoplasms
3
Head and Neck Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoid Tumor
1
Interventions
Carboplatin
339
Cisplatin
238
Paclitaxel
203
Radiotherapy
194
Pemetrexed
187
Docetaxel
169
Gemcitabine
157
pembrolizumab
140
Erlotinib Hydrochloride
107
Etoposide
98
Magnetic Resonance Spectroscopy
92
Bevacizumab
91
Specimen Handling
76
Nivolumab
73
Radiosurgery
71
durvalumab
69
Vinorelbine
54
osimertinib
53
Gefitinib
49
Drug Therapy
49
Irinotecan
42
atezolizumab
41
Topotecan
39
Radiation
39
Biopsy
39
Cyclophosphamide
38
Standard of Care
37
Cetuximab
35
Blood Specimen Collection
33
Taxes
32
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lung Neoplasms
×
fosbretabulin
×
Clear all
NCT00653939
2015-02-09
FALCON
Mateon Therapeutics
Phase 2
Completed
63 enrolled
18 charts